Novo Nordisk shares rise on promising amycretin obesity drug trial
Novo Nordisk’s amycretin shows up to 22% weight loss in trials, boosting its stock by 6.87% ...
Read moreDetails
© 2023 Tunis Mail | All Rights Reserved
Tag: weight loss treatment
Novo Nordisk tops Tesla in market value with new obesity pill
Novo Nordisk edges past Tesla in market value on successful obesity pill trial. Danish company's shares ...
Read moreDetails